Integral Health Asset Management LLC Acquires 25,000 Shares of The Cooper Companies, Inc. $COO

Integral Health Asset Management LLC raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 35.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 95,000 shares of the medical device company’s stock after acquiring an additional 25,000 shares during the period. Integral Health Asset Management LLC’s holdings in Cooper Companies were worth $6,513,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in COO. Wellington Management Group LLP grew its position in Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after purchasing an additional 4,756,178 shares during the period. Sustainable Growth Advisers LP purchased a new position in shares of Cooper Companies in the 2nd quarter worth $240,881,000. Capital World Investors boosted its stake in shares of Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock worth $723,417,000 after buying an additional 2,159,233 shares during the last quarter. Ameriprise Financial Inc. grew its holdings in shares of Cooper Companies by 98.8% in the second quarter. Ameriprise Financial Inc. now owns 3,388,413 shares of the medical device company’s stock worth $241,120,000 after acquiring an additional 1,683,561 shares during the period. Finally, Franklin Resources Inc. increased its position in Cooper Companies by 7,723.3% during the second quarter. Franklin Resources Inc. now owns 1,569,512 shares of the medical device company’s stock valued at $111,686,000 after acquiring an additional 1,549,450 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Maria Rivas acquired 1,000 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was acquired at an average cost of $82.13 per share, with a total value of $82,130.00. Following the acquisition, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Albert G. White III bought 10,000 shares of the stock in a transaction dated Tuesday, December 16th. The stock was bought at an average cost of $80.80 per share, for a total transaction of $808,000.00. Following the acquisition, the chief executive officer directly owned 236,151 shares of the company’s stock, valued at approximately $19,081,000.80. This represents a 4.42% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders purchased a total of 16,014 shares of company stock worth $1,304,416 over the last ninety days. 2.08% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the company. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. The Goldman Sachs Group reiterated a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a research note on Friday, January 9th. Rothschild & Co Redburn lowered Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective for the company. in a research note on Wednesday, March 4th. Finally, Wells Fargo & Company raised their target price on Cooper Companies from $72.00 to $82.00 and gave the stock an “equal weight” rating in a report on Friday, December 5th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $90.79.

Cooper Companies Trading Down 2.2%

Shares of COO stock opened at $69.92 on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.79 and a current ratio of 1.34. The stock has a fifty day simple moving average of $81.23 and a two-hundred day simple moving average of $75.94. The firm has a market capitalization of $13.64 billion, a PE ratio of 34.61, a PEG ratio of 1.84 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.03 by $0.07. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. During the same period in the previous year, the business earned $0.92 earnings per share. The business’s revenue was up 6.2% on a year-over-year basis. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.